HappyTidesHappyTidesAdvanced Peptides
Shop now

Learn · Topic guide

Cosmetic Copper Peptides Explained

Copper peptides occupy a distinctive corner of peptide science: small molecules that pair an amino-acid sequence with a coordinated metal ion, so that the chemistry of the metal and the chemistry of the peptide operate together. The best-characterized example in laboratory research is GHK-Cu, the 1:1 coordination complex of the tripeptide glycyl-L-histidyl-L-lysine with copper(II). It was first isolated from human plasma by Loren Pickart in 1973 and identified as a growth-modulating tripeptide. This reference article explains what cosmetic copper peptides are at the molecular level, how copper is held within the GHK scaffold, and what cell-culture and gene-expression studies report about extracellular-matrix and collagen signaling. Everything below is framed strictly around in-vitro coordination chemistry and receptor-signaling and gene-expression observations recorded in the research literature. It is not a guide to use, dosing, or any health outcome. Where peptide-specific molecular data appear, they are drawn from the curated dataset entry for GHK-Cu and its cited primary sources, including coordination geometry, collagen-synthesis concentration ranges, and transcriptomic findings.

Research use onlyStart reading ↓

Section 01

What a copper peptide is at the molecular level

A copper peptide is a metal-peptide coordination complex: an amino-acid sequence that chelates a metal ion to form a single defined species.

A copper peptide is a metal-peptide coordination complex: an amino-acid sequence that chelates a metal ion to form a single defined species. GHK-Cu is the canonical research example, classed as a copper-binding tripeptide and matricellular signaling peptide. Its peptide component is glycyl-L-histidyl-L-lysine (Gly-His-Lys, one-letter GHK), a three-residue chain. In the complex this tripeptide binds copper(II) in a 1:1 ratio, giving the molecular formula C14H22CuN6O4 and a molecular weight of 401.91 g/mol for the complex; the free, copper-free GHK tripeptide is C14H24N6O4 at 340.38 g/mol. The most commonly cited CAS number for GHK-Cu is 49557-75-7, with 89030-95-5 also registered for the Cu(II) complex and 72957-37-0 for the free tripeptide. The distinction between the apo-peptide and the copper complex matters mechanistically, because certain reported activities are attributable to the copper moiety rather than the peptide alone. Treating the complex as a single chemical entity, rather than as peptide plus loose metal, is the correct frame for reading the coordination chemistry and the cell-culture signaling data that follow in this reference.

Section 02

How copper is coordinated within the GHK scaffold

The defining feature of GHK-Cu is how the copper(II) ion is held.

The defining feature of GHK-Cu is how the copper(II) ion is held. According to the coordination study by Lau and Sarkar (1981, Biochemical Journal; PMID 7340824), the copper ion is coordinated by three nitrogen donors from the tripeptide: the imidazole nitrogen of the histidine side chain, the alpha-amino nitrogen of the N-terminal glycine, and the deprotonated glycyl-histidyl amide nitrogen of the peptide backbone. The epsilon-amino group of the lysine side chain does not directly ligate the copper but enhances the stability of the resulting complex. This arrangement is what allows GHK to function as a copper carrier and to modulate copper redox availability in vitro. Coordination chemistry is therefore not incidental to the molecule; it is the mechanism. The same three-nitrogen donor set that defines the geometry also defines the high binding affinity that lets the tripeptide hold and present copper. Reading GHK-Cu as a coordination complex, rather than as a generic peptide, is the key to understanding why several of its laboratory-observed effects track with the metal.

Section 03

Collagen and ECM signaling in fibroblast culture

The connection between copper peptides and extracellular-matrix (ECM) biology comes from cell-culture work on dermal fibroblasts.

The connection between copper peptides and extracellular-matrix (ECM) biology comes from cell-culture work on dermal fibroblasts. Maquart and colleagues (1988, FEBS Letters; PMID 3169264) reported that GHK-Cu stimulates collagen synthesis in fibroblast cultures, with maximal stimulation observed near 10^-9 M (nanomolar concentration) and independent of changes in cell number. In the dataset framing, this corresponds to increased expression of collagen type I and type III at the gene and protein level in cultured fibroblasts. A second strand of ECM-remodeling signaling involves the metalloproteinase balance: Siméon and colleagues (2000, Life Sciences; PMID 11045606) reported that GHK-Cu coordinately upregulates matrix metalloproteinase-2 (MMP-2) together with the tissue inhibitors TIMP-1 and TIMP-2 in fibroblast cultures. Notably, the MMP-2 effect was attributed to the copper moiety rather than to the copper-free peptide, reinforcing the point that the metal carries part of the signaling profile. These are in-vitro observations of gene and protein expression in defined cell systems. They describe matricellular signaling behavior in laboratory models and are not statements about any tissue-level or health outcome.

Section 04

Transcriptomic breadth and the matricellular signaling frame

Beyond individual collagen and metalloproteinase readouts, GHK has been profiled at the level of broad gene-expression programs.

Beyond individual collagen and metalloproteinase readouts, GHK has been profiled at the level of broad gene-expression programs. Pickart and Margolina (2018, International Journal of Molecular Sciences; PMID 29986520) used Connectivity Map transcriptomic data to characterize GHK as a modulator of a wide gene set. The reported breadth is striking: the analysis indicates GHK affects roughly 31.2% of human genes by at least a 50% change in expression. The pathway categories highlighted in that profiling include extracellular-matrix remodeling, antioxidant response, TGF-beta signaling, and DNA-repair pathways. This is why GHK-Cu is described in the dataset as a matricellular signaling peptide rather than a single-target ligand: its in-vitro footprint spans coordinated gene-expression changes rather than one isolated receptor event. The earlier review by Pickart, Vasquez-Soltero and Margolina (2015, BioMed Research International; PMID 26236730) situates the same tripeptide within multiple cellular-pathway models in skin-cell systems. All of these are transcriptomic and gene-expression observations recorded in cell-based and database analyses. They establish a mechanistic profile in model systems and do not translate to any claim of efficacy.

Section 05

Where GHK-Cu sits among ECM-relevant research peptides

None of these three shares GHK-Cu's defining trait, which is metal coordination as the basis of activity.

GHK-Cu is the principal copper peptide in cosmetic-adjacent research, but it is useful to place it next to other ECM- and cytoskeleton-relevant peptides studied in laboratory settings, drawn from the same dataset. TB-500, the N-acetylated thymosin beta-4 fragment Ac-LKKTETQ, operates through a different mechanism: in cell-free and cultured-cell systems its parent peptide acts as a G-actin (monomeric actin) sequestering peptide via the conserved LKKTET actin-binding motif, regulating cytoskeletal dynamics rather than coordinating a metal. BPC-157, a synthetic pentadecapeptide, is studied as a modulator of endothelial and fibroblast signaling, including FAK and paxillin phosphorylation and F-actin assembly in tendon-fibroblast cultures. None of these three shares GHK-Cu's defining trait, which is metal coordination as the basis of activity. The contrast clarifies what makes copper peptides their own category: the chemistry is inseparable from the coordinated copper(II) ion. As a general principle of peptide science, sequence determines binding and folding, but in metal-peptide complexes the coordinated ion adds a second, redox-active dimension that a peptide alone does not possess. These remain in-vitro and receptor-signaling characterizations.

Straight answers

Frequently asked questions

What is GHK-Cu chemically?

GHK-Cu is the 1:1 coordination complex of the tripeptide glycyl-L-histidyl-L-lysine (Gly-His-Lys) with copper(II). The complex has the molecular formula C14H22CuN6O4 and a molecular weight of 401.91 g/mol. The copper-free GHK tripeptide is C14H24N6O4 at 340.38 g/mol. It is classed in the dataset as a copper-binding tripeptide and matricellular signaling peptide.

How is the copper ion held in the complex?

Per Lau and Sarkar (1981, Biochemical Journal; PMID 7340824), copper(II) is coordinated by the imidazole nitrogen of histidine, the alpha-amino nitrogen of glycine, and the deprotonated glycyl-histidyl amide nitrogen. The lysine epsilon-amino group does not directly bind the copper but increases the stability of the complex.

What do cell-culture studies report about collagen?

Maquart and colleagues (1988, FEBS Letters; PMID 3169264) reported that GHK-Cu stimulates collagen synthesis in dermal-fibroblast cultures, with maximal stimulation near 10^-9 M (nanomolar) and independent of changes in cell number. The dataset frames this as increased collagen type I and type III gene and protein expression. These are in-vitro observations only.

What role does copper itself play versus the peptide?

The distinction matters mechanistically. Siméon et al. (2000, Life Sciences; PMID 11045606) reported that GHK-Cu coordinately upregulates MMP-2 along with TIMP-1 and TIMP-2 in fibroblast cultures, and attributed the MMP-2 effect specifically to the copper moiety rather than to the copper-free peptide. The complex behaves as a single entity in which the coordinated copper carries part of the signaling profile.

How broad is GHK's reported effect on gene expression?

Connectivity Map transcriptomic analysis reported by Pickart and Margolina (2018, International Journal of Molecular Sciences; PMID 29986520) indicates GHK affects roughly 31.2% of human genes by at least a 50% change in expression, across gene sets associated with extracellular-matrix remodeling, antioxidant response, TGF-beta signaling, and DNA-repair pathways. These are database and cell-based gene-expression observations.

How does GHK-Cu differ from other ECM-relevant research peptides?

Its defining trait is metal coordination. By contrast, TB-500 (Ac-LKKTETQ, a thymosin beta-4 fragment) acts in cell-free and cultured systems as a G-actin sequestering peptide via the LKKTET motif, and BPC-157 is studied as a modulator of endothelial and fibroblast signaling. Neither relies on a coordinated metal ion, which is what places GHK-Cu in its own category.

Where was GHK first identified?

GHK was isolated from human plasma by Loren Pickart in 1973 and identified as a growth-modulating tripeptide. It has also been reported to occur in human plasma, saliva, and urine, per the review literature cited in the dataset (Pickart & Margolina 2018, PMID 29986520).

Keep exploring

Continue learning

Topic guideWhat Are Research Peptides?Research peptides are short chains of amino acids studied in the laboratory to understand how cells receive, interpret, and relay molecular signals. Because peptides sit at the size boundary between simple amino acids and large folded proteins, they make precise tools for asking narrow biochemical questions: which receptor does a given sequence engage, what second messenger rises inside the cell, and how does a small change to the chain alter that behavior? This reference looks at what defines a peptide, how peptides differ from proteins, what the label "research use only" (RUO) means, and why these molecules are examined in cell-based and cell-free systems rather than treated as finished products. Throughout, the framing is strictly in-vitro and receptor-signaling: the discussion concerns binding assays, cultured cells, isolated tissues, and structure-activity studies. Specific peptide facts cited here are drawn from a curated reference dataset of characterized research peptides. General principles of peptide chemistry are presented as established background. Nothing here describes administration, outcomes, or use in people; the goal is conceptual literacy for laboratory and educational contexts.Read →Topic guidePeptide Classes ExplainedPeptides are short chains of amino acids, and in laboratory research they are rarely studied as an undifferentiated group. Investigators sort them by what they do at the molecular level: which receptor they bind, which intracellular cascade they trigger, or which biochemical process they modulate in a cell-free or cultured-cell system. This reference organizes a set of research peptides by functional class rather than by chemical size or origin. The groupings used here are growth hormone secretagogues, incretin-receptor agonists, regenerative and matrix-signaling peptides, nootropic neuropeptides, cosmetic matricellular peptides, and mitochondrial-derived peptides. Each class is defined by a shared mechanistic signature observed in receptor-binding assays, second-messenger readouts, or gene-expression profiling. Every peptide-specific statement below is drawn from a curated dataset of in-vitro and structural findings, and the framing is strictly that of laboratory research: receptor occupancy, signal transduction, and biochemical activity. No human dosing, clinical outcome, or disease-treatment interpretation is offered. The goal is a clear conceptual map of how research peptides differ in molecular target and signaling logic.Read →Topic guideGrowth Hormone Secretagogues ExplainedGrowth hormone secretagogues (GHS) are a research category defined by mechanism rather than chemistry: each is a molecule that, in laboratory and cell-based systems, prompts pituitary somatotroph cells to release stored growth hormone instead of supplying growth hormone from outside the system. The category splits cleanly into two receptor branches. One branch acts at the growth hormone-releasing hormone receptor (GHRH-R); the other acts at the growth hormone secretagogue receptor type 1a (GHS-R1a), the receptor for endogenous ghrelin. These two receptors sit on the same cells but run through different G-protein cascades, which is why the distinction matters at the bench. This reference article explains GHS-R1a signaling, contrasts GHRH analogs with ghrelin-mimetic growth hormone-releasing peptides (GHRPs), describes why GH release is pulsatile, and clarifies the conceptual line between a secretagogue and an exogenous hormone. All statements here are framed strictly around in-vitro and receptor-signaling observations in research models. Peptide-specific facts are drawn only from a controlled reference dataset; broader statements are presented as general principles of peptide endocrinology, not as claims about any outcome.Read →Topic guideGHRH Analogs vs GHRPsTwo families of research peptides frequently appear together in growth-hormone-axis signaling studies: growth-hormone-releasing hormone (GHRH) analogs and growth-hormone-releasing peptides (GHRPs). Although both are described in the literature as growth hormone secretagogues, they engage entirely different cell-surface receptors and trigger different intracellular second-messenger cascades in laboratory models. GHRH analogs such as sermorelin and CJC-1295 act at the GHRH receptor (GHRHR), a class B Gs-coupled G-protein-coupled receptor on pituitary somatotroph cells. GHRPs such as GHRP-2 act at the growth hormone secretagogue receptor type 1a (GHS-R1a) - the ghrelin receptor - a class A GPCR coupled to a separate signaling arm. This article compares the two receptor systems as characterized in in-vitro and ex-vivo work, explains why their pathways are described as complementary, and grounds each peptide-specific claim in the reference dataset. The framing throughout is strictly receptor-signaling and laboratory-research: cAMP and calcium readouts in cultured cells, binding constants, and structure-activity relationships, not clinical outcomes. Understanding the receptor-level distinction clarifies why these two peptide classes are studied as separate but convergent inputs onto the somatotroph.Read →

For in-vitro laboratory research use only. Not for human or animal consumption. Educational content, not medical advice; not intended to diagnose, treat, cure, or prevent any disease. Not evaluated by the FDA.